Transcriptional signatures differentiate pathogen- and treatment-specific host responses in patients with bacterial bloodstream infections

By sjmartinez • November 25, 2023

Thaden JT, Ahn R, Ruffin F, Gjertson DW, Hoffmann A, Fowler VG Jr, Yeaman MR. Transcriptional signatures differentiate pathogen- and treatment-specific host responses in patients with bacterial bloodstream infections. J Infect Dis. 2023 Nov 24:jiad498. doi: 10.1093/infdis/jiad498. Epub ahead of print. PMID: 38001039.

Tags: bacteremia, Escherichia coli, Infectious Diseases, Klebsiella pneumoniae, Molecular Medicine, Publications, Staphylococcus aureus, transcriptome

Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial

Edupuganti S, Hurt CB, Stephenson KE, Huang Y, Paez CA, Yu C, Yen C, Hanscom B, He Z, Miner MD, Gamble T, Heptinstall J, Seaton[...]

Cluster of Extensively Drug-Resistant Shigella sonnei Carrying blaCTX-M-15 in Los Angeles, California, 2023-2024

Caldera JR, Shaw B, Uslan DZ, Yang S. Cluster of Extensively Drug-Resistant Shigella sonnei Carrying blaCTX-M-15 in Los Angeles, California, 2023-2024. Am J Infect Control. 2024[...]

Hepatotoxicity Score: A New Method to Adjust for Use of Potentially Hepatotoxic Medications by Chronic Liver Disease Status

Lo Re V 3rd, Newcomb CW, Carbonari DM, Mezochow AK, Hennessy S, Rentsch CT, Park LS, Tate JP, Bräu N, Bhattacharya D, Lim JK, Mezzacappa[...]